Studies have shown that a large amount of tumor mesenchyme (50%–90%) is present in most malignant lesions, and high expression of FAP is closely associated with invasion, metastasis, and poor prognosis of these malignant tumors, suggesting that FAP is promising as an essential target for malignant tumor imaging and treatment (11, 12). The gene discussed is FAP; the disease is cancer.